Visualizing disease associations: Graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease

Genetic Epidemiology

Volumn 34, Issue 1, 2010, Pages 92-99

  Payami, Haydeh ^a   Kay, Denise M ^a   Zabetian, Cyrus P ^b,c   Schellenberg, Gerard D ^d   Factor, Stewart A ^e   McCulloch, Colin C ^f  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GE GLOBAL RESEARCH   (United States)

Author keywords

APOE; Coffee; GWAS; MAPT; SNCA

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E; MARKER;

AGE DISTRIBUTION; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; COFFEE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EXPOSURE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; ONSET AGE; PARKINSON DISEASE; QUANTITATIVE TRAIT; STANDARD; STATISTICS;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; PARKINSON DISEASE; RISK FACTORS;

AVES;

EID: 75649085326     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20439     Document Type: Article

References (20)

1. Bernardo J, Smith A. 2000. Bayesian Theory. Chichester, UK: Wiley.
2. Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Kruger R, Marder KS, Mayeux RP, Mellick GD, Nutt JG, Ritz B, Samii A, Tanner CM, Van Broeckhoven C, Van Den Eeden SK, Wirdefeldt K, Zabetian CP, Dehem M, Montimurro JS, Southwick A, Myers RM, Trikalinos TA. 2006. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol 5:917-923.
3. Healy DG, Abou-Sleiman PM, Lees AJ, Casas JP, Quinn N, Bhatia K, Hingorani AD, Wood NW. 2004. Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry 75:962-965.
4. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. 2002. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284.
5. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. 2002. A comprehensive review of genetic association studies. Genet Med 4:45-61.
6. Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG,Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H. 2008. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 147B:1222-1230.
7. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C, Raby BA, Lazarus R, Klanderman B, Soto-Quiros ME, Avila L, Silverman EK, Thorleifsson G, Thorsteinsdottir U, Kronenberg F, Vollmert C, Illig T, Fox CS, Levy D, Laird N, Ding X, McQueen MB, Butler J, Ardlie K, Papoutsakis C, Dedoussis G, O'Donnell CJ, Wichmann HE, Celedon JC, Schadt E, Hirschhorn J, Weiss ST, Stefansson K, Lange C. 2008. On the replication of genetic associations: timing can be everything! Am J Hum Genet 82:849-858.
8. Maraganore DM, de Andrade M, Lesnick TG, Strain KJ, Farrer MJ, Rocca WA, Pant PV, Frazer KA, Cox DR, Ballinger DG. 2005. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77:685-693.
9. Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Kruger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C. 2006. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. J Am Med Assoc 296:661-670.
10. McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H. 2008. Exploring gene-environment interactions in Parkinson's disease. Hum Genet 123:257-265.
11. Pankratz N, Byder L, Halter C, Rudolph A, Shults CW, Conneally PM, Foroud T, Nichols WC. 2006. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Mov Disord 21:45-49.
12. Pankratz N, Wilk J, Latourelle J, Destefano A, Haletr C, Pugh E, Doheny K, Gusella J, Nichols W, Foroud T, Myers R. 2008. Genomewide association study for susceptibility genes contributing to familial Parkinson's disease. Hum Genet [epub ahead of print].
13. Payami H, Joe S, Farid NR, Stenszki V, Chan SH, Thomson G. 1989. Relative predispositional effects (RPE's) of marker alleles with disease: HLA-DR and autoimmune thyroid disease. Am J Hum Genet 45:541-546.
14. Payami H, Kaye J, Heston LL, Bird TD, Schellenberg GD. 1993. Apolipoprotein E genotypes and Alzheimer's disease. Lancet 342:738.
15. Payami H, Zhu M, Montimurro J, Keefe R, McCulloch CC, Moses L. 2005. One step closer to fixing association studies: evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls. Hum Genet 118:322-330.
16. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di lorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzzrini AM, Nussbaum RL, Duvoisin RC. 1996. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274:1197-1199.
17. Powers K, Kay D, Factor S, Zabetian C, Higgins D, Samii A, Nutt J, Griffith A, Leis B, Roberts J, Martinez E, Montimurro J, Checkoway H, Payami H. 2008. Combined effects of smoking, coffee and NSAIDs on Parkinson's disease risk. Mov Disord 23:88-95.
18. Yu CE, Seltman H, Peskind ER, Galloway N, Zhou PX, Rosenthal E, Wijsman EM, Tsuang DW, Devlin B, Schellenberg GD. 2007. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics 89:655-665.
19. Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H. 2007. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 62:137-144.
20. Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H. 2002. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 107:156-161.